ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 625

$977K Total Retail Price of All Prescriptions

Rank: 26 out of 625

521 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LISINOPRIL 389 326 1 5
HYDROCODONE-ACETAMINOPHEN 376 246 S3 2 4
LEVOTHYROXINE SODIUM 376 333 2 3
ATORVASTATIN CALCIUM 360 332 4 9
SIMVASTATIN 322 299 5 2
FUROSEMIDE 320 277 6 7
ZOLPIDEM TARTRATE 295 247 7 13
OMEPRAZOLE 280 233 8 6
AMLODIPINE BESYLATE 273 247 9 1
METOPROLOL TARTRATE 257 238 10 11
METFORMIN HCL 207 187 11 10
NEXIUM 197 172 12 21
ALENDRONATE SODIUM 180 165 13 34
CRESTOR 178 155 14 17
GABAPENTIN 170 125 15 14
TAMSULOSIN HCL 168 156 16 36
LOSARTAN POTASSIUM 167 157 17 18
HYDROCHLOROTHIAZIDE 165 143 18 12
PRAVASTATIN SODIUM 161 145 19 8
TRAMADOL HCL 159 124 20 16
SERTRALINE HCL 149 141 21 26
WARFARIN SODIUM 148 145 22 20
ZETIA 140 116 23 66
POTASSIUM CHLORIDE 135 127 24 19
CITALOPRAM HBR 133 122 25 24
CYMBALTA 117 93 26 46
METOPROLOL SUCCINATE 117 115 26 15
CARVEDILOL 113 99 28 23
CLOPIDOGREL 103 91 29 30
LANTUS 101 82 30 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 94 31 27
DIOVAN 99 93 32 28
ATENOLOL 95 95 33 22
TRIAMTERENE-HCTZ 90 83 34 53
ESCITALOPRAM OXALATE 90 85 34 67
CLONIDINE HCL 84 83 36 50
LOSARTAN-HYDROCHLOROTHIAZIDE 84 77 36 38
FLUTICASONE PROPIONATE 84 65 36 32
DONEPEZIL HCL 83 83 39 33
JANUVIA 77 36 40 74
AMITRIPTYLINE HCL 74 57 R 41 61
SPIRIVA 74 46 41 70
ALLOPURINOL 67 51 43 29
PLAVIX 67 64 43 43
NAMENDA 67 67 43 45
LYRICA 66 45 46 71
NOVOLOG 65 43 47 112
FINASTERIDE 65 65 47 139
KLOR-CON M20 63 46 49 47
INSULIN SYRINGE 60 48 50 77
PREDNISONE 60 48 50 37
GLIPIZIDE ER 60 52 50 68
VITAMIN D2 59 44 53 341
WELCHOL 58 54 54 232
AZITHROMYCIN 58 36 54 40
BYSTOLIC 58 33 54 97
SYNTHROID 56 52 57 39
VESICARE 56 56 57 193
MELOXICAM 54 52 59 31
RANITIDINE HCL 52 33 60 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.